Finland· FI-REL-REL54205
Nustendi
A bempedoic acid and ezetimibe product containing bempedoic acid + ezetimibe, registered in Finland by Daiichi Sankyo Europe GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Bempedoic acid and ezetimibe is registered in 10 of 19 countries.
Countries holding a registration under ATC C10BA10 (bempedoic acid and ezetimibe), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Bempedoic acid and ezetimibe · ATC C10BA10
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Bempedoic Acid + Ezetimibe
- Manufacturer
- Daiichi Sankyo Europe GmbH
- Country
- Finland (FI)
- ATC code
- C10BA10
- ATC class
- Bempedoic acid and ezetimibe
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bempedoic acid and ezetimibe in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNUSTENDIDaiichi Sankyo Europe GmbH, Mnichov
- United KingdomNustendi 180mg/10mg tabletsPilsco Ltd
- SwitzerlandNustendi 180 mg / 10 mg, FilmtablettenDaiichi Sankyo (Schweiz) AG
- United StatesNexlizetEsperion Therapeutics, Inc.
- IcelandNustendiDAIICHI SANKYO EUROPE GmbH*
- NetherlandsNustendi 180 mg/10 mg filmomhulde tablettenDAIICHI SANKYO EUROPE GmbH
- PolandNustendiDaiichi Sankyo Europe GmbH
- SwedenNustendi 180 mg/10 mg Filmdragerad tablettDaiichi Sankyo Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nustendi
- Liechtenstein · Nustendi
- Norway · Nustendi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c08fe62f-dcae-4575-a589-ed8ca3f40df4 GET /v1/drugs/c08fe62f-dcae-4575-a589-ed8ca3f40df4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "180 mg / 10 mg",
"atc_label": "bempedoiinihappo ja etsetimibi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/20/1424/001-011",
"fimea_rel_id": "REL54205",
"authorised_at": "2020-03-27"
}See everything about bempedoic acid and ezetimibe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.